-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly completed the acquisition of Ataibekley to advance research and development of treatments for intractable depression and other mental illnesses.

Zhitongcaijing·09/11/2026 13:09:03
Listen to the news
Eli Lilly completed the acquisition of Ataibekley to advance research and development of treatments for intractable depression and other mental illnesses.